Literature DB >> 16884658

Monitoring vascular health beyond blood pressure.

Daniel A Duprez1, Jay N Cohn.   

Abstract

It is well recognized that vascular changes, including atherosclerosis, begin early in life as a silent, asymptomatic disease process and are associated with cardiovascular (CV) risk factors. Importantly, CV risk factors persist or track from childhood to adulthood and are predictive of CV disease risk in adults. Evaluation of arterial stiffness and its predictors may help identify asymptomatic individuals at risk, before blood pressure is elevated above an "arbitrary" level that we currently identify as hypertension. Currently, measurements of arterial stiffness are being used in the research setting and also as part of cardiovascular risk prediction clinics. As the various techniques become more widely available, it is conceivable that the measurement of arterial stiffness could become an important part of the routine assessment of patients in daily practice, as a supplement to blood pressure measurement. Measurement of arterial stiffness will not only be helpful in the detection of early vascular disease but also will be a tool in the follow-up monitoring of strategies aimed at preventing hypertension or reducing further progression of vascular disease before blood pressure elevation can be detected.

Entities:  

Mesh:

Year:  2006        PMID: 16884658     DOI: 10.1007/s11906-006-0066-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  53 in total

1.  Pulse waveform analysis and arterial wall properties.

Authors:  Gary E McVeigh
Journal:  Hypertension       Date:  2003-04-07       Impact factor: 10.190

2.  First- and third-order models for determining arterial compliance.

Authors:  S M Finkelstein; J N Cohn
Journal:  J Hypertens Suppl       Date:  1992-08

3.  Role of arterial wall properties in the pathogenesis of systolic hypertension.

Authors:  Gérard M London
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

4.  Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects.

Authors:  John Dernellis; Maria Panaretou
Journal:  Hypertension       Date:  2005-02-14       Impact factor: 10.190

5.  Arterial stiffness and the development of hypertension. The ARIC study.

Authors:  D Liao; D K Arnett; H A Tyroler; W A Riley; L E Chambless; M Szklo; G Heiss
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

6.  Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.

Authors:  D A Duprez; P E Somasundaram; G Sigurdsson; L Hoke; N Florea; J N Cohn
Journal:  J Hum Hypertens       Date:  2005-07       Impact factor: 3.012

7.  Flow-mediated vasodilation and distensibility in relation to intima-media thickness of large arteries in mild essential hypertension.

Authors:  M Barenbrock; M Hausberg; M Kosch; S A Golubev; K Kisters; K H Rahn
Journal:  Am J Hypertens       Date:  1999-10       Impact factor: 2.689

8.  Effects of chronic administration of enalapril and propranolol on the large arteries in essential hypertension.

Authors:  A C Simon; J Levenson; J D Bouthier; M E Safar
Journal:  J Cardiovasc Pharmacol       Date:  1985 Sep-Oct       Impact factor: 3.105

Review 9.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors:  J Stamler; R Stamler; J D Neaton
Journal:  Arch Intern Med       Date:  1993-03-08

10.  Plasma noradrenaline response to a multistage exercise test in young men at increased risk of developing essential hypertension.

Authors:  J R Nielsen; L F Gram; P K Pedersen
Journal:  J Hypertens       Date:  1989-05       Impact factor: 4.844

View more
  11 in total

1.  Lack of fit in self modeling regression: application to pulse waveforms.

Authors:  Lyndia C Brumback; Douglas Tommet; Richard Kronmal
Journal:  Int J Biostat       Date:  2010-01-14       Impact factor: 0.968

2.  Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation.

Authors:  Joanna Lecka; Manjit Singh Rana; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Aorta pulse wave velocity and augmentation index: can it be simpler?

Authors:  D A Duprez
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

4.  Invited Commentary: Hypertension and Arterial Stiffness--Origins Remain a Dilemma.

Authors:  David R Jacobs; Daniel A Duprez; Daichi Shimbo
Journal:  Am J Epidemiol       Date:  2016-03-08       Impact factor: 4.897

Review 5.  Arterial stiffness as a risk factor for coronary atherosclerosis.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

6.  Race/ethnic and sex differences in large and small artery elasticity--results of the multi-ethnic study of atherosclerosis (MESA).

Authors:  Daniel A Duprez; David R Jacobs; Pamela L Lutsey; David Herrington; Darryl Prime; Pamela Ouyang; R Graham Barr; David A Bluemke
Journal:  Ethn Dis       Date:  2009       Impact factor: 1.847

7.  Arterial Stiffness Index and Coronary Artery Plaques in Patients with Subclinical Coronary Atherosclerosis.

Authors:  Yung-Ta Kao; Sen-Te Wang; Chun-Ming Shih; Feng-Yen Lin; Nai-Wen Tsao; Kuang-Hsing Chiang; Chao-Shun Chan; Yen-Chung Lin; Ming-Yow Hung; Ming-Hsiung Hsieh; Kuo-Gi Shyu; Jaw-Wen Chen; Nen-Chung Chang; Jong-Shiuan Yeh; Chun-Yao Huang
Journal:  Acta Cardiol Sin       Date:  2015-01       Impact factor: 2.672

Review 8.  Does it matter how you lower blood pressure in patients with uncomplicated hypertension? Weighing the evidence.

Authors:  Daniel A Duprez
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

9.  Association between Endothelial Biomarkers and Arterial Elasticity in Young Adults - The CARDIA Study.

Authors:  Narayanan I Valappil; David R Jacobs; Daniel A Duprez; Myron D Gross; Donna K Arnett; Stephen Glasser
Journal:  J Am Soc Hypertens       Date:  2008 Mar-Apr

Review 10.  Identifying early cardiovascular disease to target candidates for treatment.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.